NCT02513823

Brief Summary

This pilot study will examine the effectiveness of vitamin D supplementation on reducing blood pressure and improving endothelial function. Premenopausal African American women will be recruited. Participants will be instructed to record food intake for three days to estimate usual dietary intake at baseline and at the 10th week. At the baseline clinic visit a 10 week supply of vitamin D3 supplements (2,000 IU/day; Nature Made ®) will be given to participants and log sheets provided to record supplement intake. To answer the primary research questions, within subjects repeated measures analysis of variance (ANOVA) tests will be conducted to test if any differences in blood pressure, serum 25(OH)D concentrations, and RHI are statistically different after 10 weeks of supplementation with 2,000 IU/d of vitamin D. Exploratory multivariate linear regression models will be constructed to determine relationships between vitamin D status and vascular function parameters (blood pressure, RHI) before and after adjustment for age and BMI.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2015

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 3, 2015

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2015

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 14, 2016

Completed
3 years until next milestone

Results Posted

Study results publicly available

October 4, 2019

Completed
Last Updated

October 4, 2019

Status Verified

October 1, 2019

Enrollment Period

8 months

First QC Date

July 30, 2015

Results QC Date

April 13, 2018

Last Update Submit

October 2, 2019

Conditions

Keywords

blood pressurevitamin D

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of Vitamin D Supplementation on Reducing Blood Pressure

    Changes in systolic and diastolic blood pressure will be measured at baseline and following vitamin D supplementation for 10 weeks in African American healthy pre-menopausal women

    Baseline and 10 weeks

Secondary Outcomes (1)

  • Effectiveness of Vitamin d Supplementation on Improving Endothelial Function

    Baseline and 10 weeks

Study Arms (1)

Intervention

EXPERIMENTAL

2,000 IU of vitamin D given to African American women for 10 weeks

Dietary Supplement: 2,000 International Units (IU)of vitamin D3

Interventions

2,000 IU vitamin D taken daily for 10 weeks

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy pre-menomausal African American women

You may not qualify if:

  • History of elevated blood pressure \>140/90 mm Hg
  • Pregnant or planning to become pregnant in the next three months
  • Lactating
  • Known Crohn's
  • Inflammatory bowel disease
  • Previous bowel resections
  • Bariatric surgeries, or psoriasis
  • Artificial or long fingernails they do not want to cut for testing
  • Regularly taking medications that might affect endothelial function such as anti-inflammatory medications, statins, anti-hypertensive medication, daily aspirin, non-SSRI psychotropic medication, and dietary supplements including vitamin D supplements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Methodist Hospital

Houston, Texas, 77030, United States

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Results Point of Contact

Title
Carolyn Moore
Organization
Texas Woman's University

Study Officials

  • Carolyn Moore, PHD, RD, LD

    Methodist Hosptial

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 30, 2015

First Posted

August 3, 2015

Study Start

December 1, 2015

Primary Completion

August 1, 2016

Study Completion

October 14, 2016

Last Updated

October 4, 2019

Results First Posted

October 4, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations